Opportunity Information: Apply for PAR 18 510

The grant opportunity titled "Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R01)" (Funding Opportunity Number PAR-18-510) is a discretionary National Institutes of Health (NIH) research project grant designed to advance scientific understanding of synthetic psychoactive drugs and to translate that knowledge into practical strategies that reduce harm. The core purpose is to support research that clarifies how and why these substances are used, how they work in the body and brain, what short- and long-term health consequences they produce, and which prevention and treatment approaches are most effective. A major emphasis is placed not only on basic and mechanistic insights, but also on applied work that can improve clinical responses in emergency department settings as well as longer-range treatment and recovery outcomes.

This funding opportunity centers on several connected research priorities. One priority is strengthening the evidence base on patterns of use, including who uses synthetic psychoactive drugs, under what conditions, and what social or environmental factors contribute to initiation, escalation, and repeated exposure. Another priority is investigating mechanisms of action, meaning the biological targets and pathways these drugs affect, how different compounds may vary in potency or toxicity, and how those differences translate into acute intoxication, adverse events, dependence, or other outcomes. The FOA also seeks studies that characterize health effects across time, which can include immediate harms that bring people to emergency care as well as longer-term physical and mental health effects. Finally, the opportunity explicitly calls for development and testing of prevention strategies and treatment strategies, including approaches tailored to emergency departments (where rapid recognition and management are critical) and approaches aimed at longer-term care, follow-up, and sustained recovery.

The funding instrument is an NIH R01, which generally supports a defined, investigator-driven research project. The Funding Activity Category listed for this opportunity is Education and Health, and the CFDA number associated with it is 93.279. While the specific award ceiling and the number of expected awards are not provided in the source text, the R01 mechanism typically supports substantial, multi-year research programs where applicants can justify the scope, staffing, and resources needed to answer focused scientific questions and produce actionable findings.

Eligibility is broad and includes many types of domestic applicants as well as certain non-U.S. organizations. Eligible applicants include state, county, city or township governments; special district governments; independent school districts; and public housing authorities/Indian housing authorities. Academic institutions are eligible, including public and state-controlled institutions of higher education and private institutions of higher education. Tribal eligibility includes federally recognized Native American tribal governments and Native American tribal organizations other than federally recognized tribal governments, and the FOA also highlights Indian/Native American Tribal Governments (other than Federally Recognized) as additional eligible applicants. Nonprofit organizations are eligible whether they have 501(c)(3) status or not (so long as they are not institutions of higher education under those categories), and for-profit organizations other than small businesses, as well as small businesses, are also eligible. The opportunity further emphasizes inclusivity for a range of mission-driven and community-rooted institutions, explicitly listing Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); faith-based or community-based organizations; eligible federal government agencies; regional organizations; U.S. territories or possessions; and non-domestic (non-U.S.) entities (foreign organizations).

Key administrative details from the source information include that the opportunity was created on 2017-12-18 and listed an original closing date of 2020-05-07. The sponsoring agency is the National Institutes of Health. Overall, the FOA is aimed at generating rigorous, actionable research that helps the public health and clinical systems better understand synthetic psychoactive drugs and respond more effectively through prevention, acute care improvements in emergency departments, and stronger longer-term treatment strategies.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R01 )" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
  • This funding opportunity was created on 2017-12-18.
  • Applicants must submit their applications by 2020-05-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 18 510

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

What is the title of this grant opportunity?

The opportunity is titled "Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R01)."

What is the Funding Opportunity Number (FOA number)?

The Funding Opportunity Number is PAR-18-510.

Which agency sponsors this funding opportunity?

The sponsoring agency is the National Institutes of Health (NIH).

What type of grant mechanism is this?

This opportunity uses the NIH R01 mechanism, described as a research project grant that generally supports a defined, investigator-driven research project.

What is the main purpose of this R01 opportunity?

The core purpose is to advance scientific understanding of synthetic psychoactive drugs and translate that knowledge into practical strategies that reduce harm. It supports research on why and how these substances are used, how they work in the body and brain, what short- and long-term health consequences they produce, and what prevention and treatment approaches are most effective.

What kinds of research topics does the FOA emphasize?

The opportunity emphasizes connected priorities that include patterns of use, mechanisms of action, health effects over time, and development and testing of prevention and treatment strategies, including emergency department-focused approaches and longer-term treatment and recovery approaches.

What does the FOA mean by "patterns of use" research?

Patterns of use research includes understanding who uses synthetic psychoactive drugs, under what conditions they are used, and which social or environmental factors contribute to initiation, escalation, and repeated exposure.

What does "mechanisms of action" refer to in this opportunity?

Mechanisms of action refers to studying the biological targets and pathways these drugs affect, how different compounds vary in potency or toxicity, and how those differences relate to outcomes such as acute intoxication, adverse events, dependence, or other effects.

Does the opportunity support research on both immediate and long-term health effects?

Yes. The FOA seeks studies that characterize health effects across time, including immediate harms that may lead to emergency care as well as longer-term physical and mental health effects.

Is emergency department (ED) research specifically encouraged?

Yes. A major emphasis includes applied work that can improve clinical responses in emergency department settings, where rapid recognition and management are critical.

Does the FOA also support longer-term treatment and recovery research?

Yes. The opportunity explicitly calls for approaches aimed at longer-term care, follow-up, and sustained recovery outcomes, in addition to emergency department-focused strategies.

Does this FOA support prevention strategy research?

Yes. The FOA explicitly calls for the development and testing of prevention strategies as part of its priorities.

Does this FOA support treatment strategy research?

Yes. The FOA explicitly calls for development and testing of treatment strategies, including those tailored to emergency departments and those targeting longer-term treatment and recovery.

What is the Funding Activity Category listed for this opportunity?

The Funding Activity Category is Education and Health.

What CFDA number is associated with this grant opportunity?

The CFDA number associated with this opportunity is 93.279.

Are funding limits (award ceiling) or the expected number of awards provided?

No. The source information does not provide a specific award ceiling or the expected number of awards.

What does the description suggest about the typical scale of an R01 project?

While specific limits are not provided in the source text, it notes that the R01 mechanism typically supports substantial, multi-year research programs where applicants justify the scope, staffing, and resources needed to answer focused scientific questions and produce actionable findings.

Who is eligible to apply?

Eligibility is broad and includes many domestic applicants as well as certain non-U.S. organizations. The source information lists multiple eligible applicant types across government, academic, nonprofit, for-profit, tribal, community-based, and other organizational categories.

Are state and local governments eligible?

Yes. Eligible applicants include state governments, county governments, city or township governments, and special district governments.

Are public education entities eligible, such as independent school districts?

Yes. Independent school districts are listed as eligible applicants.

Are public housing authorities eligible?

Yes. Public housing authorities/Indian housing authorities are listed as eligible applicants.

Are colleges and universities eligible?

Yes. Eligible academic institutions include public and state-controlled institutions of higher education as well as private institutions of higher education.

Are tribal governments and tribal organizations eligible?

Yes. Eligibility includes federally recognized Native American tribal governments and Native American tribal organizations other than federally recognized tribal governments. The source also highlights Indian/Native American Tribal Governments (other than Federally Recognized) as additional eligible applicants.

Are nonprofit organizations eligible?

Yes. Nonprofit organizations are eligible whether they have 501(c)(3) status or not, as long as they are not applying under the institutions of higher education categories referenced in the source text.

Are for-profit organizations eligible?

Yes. For-profit organizations other than small businesses are listed as eligible, and small businesses are also listed as eligible.

Are community-based or faith-based organizations eligible?

Yes. The FOA explicitly lists faith-based or community-based organizations among eligible applicants.

Are minority-serving institutions specifically included as eligible applicants?

Yes. The FOA explicitly lists Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); and Tribally Controlled Colleges and Universities (TCCUs).

Are federal agencies eligible to apply?

Yes. Eligible federal government agencies are listed among eligible applicants.

Are regional organizations eligible?

Yes. Regional organizations are explicitly listed as eligible applicants.

Are U.S. territories or possessions eligible?

Yes. U.S. territories or possessions are listed as eligible applicants.

Are non-U.S. (foreign) organizations eligible to apply?

Yes. The source information states that non-domestic (non-U.S.) entities (foreign organizations) are eligible.

When was this funding opportunity created?

The opportunity was created on 2017-12-18.

What closing date is listed in the source information?

The source information lists an original closing date of 2020-05-07.

What overall outcomes is the FOA trying to support?

The FOA is aimed at generating rigorous, actionable research to help public health and clinical systems better understand synthetic psychoactive drugs and respond more effectively through prevention, improvements in emergency department acute care, and stronger longer-term treatment strategies.

Does the FOA focus only on basic science, or also on applied/clinical work?

It emphasizes both. The opportunity highlights basic and mechanistic insights as well as applied work intended to improve emergency department responses and longer-range treatment and recovery outcomes.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R21 Clinical Trial Optional)

Previous opportunity: Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R01 Clinical Trial Optional)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 18 510

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 18 510) also looked into and applied for these:

Funding Opportunity
Innovative Questions in Symptom Science and Genomics (R15 Clinical Trial Not Allowed) Apply for PA 18 471

Funding Number: PA 18 471
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Personalized Strategies to Manage Symptoms of Chronic Illness (R15 Clinical Trial Not Allowed) Apply for PA 18 472

Funding Number: PA 18 472
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R21 Clinical Trial Optional ) Apply for PAR 18 509

Funding Number: PAR 18 509
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R01 Clinical Trial Optional) Apply for PA 18 348

Funding Number: PA 18 348
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Self-Management for Health in Chronic Conditions (R01 Clinical Trial Optional) Apply for PA 18 376

Funding Number: PA 18 376
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Community Partnerships to Advance Research (CPAR) (R01 Clinical Trial Optional) Apply for PA 18 377

Funding Number: PA 18 377
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Community Partnerships to Advance Research (CPAR) (R15 Clinical Trial Not Allowed) Apply for PA 18 475

Funding Number: PA 18 475
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Self-Management for Health in Chronic Conditions (R15 Clinical Trial Not Allowed) Apply for PA 18 474

Funding Number: PA 18 474
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Early-life Factors and Cancer Development Later in Life (R03 - Clinical Trial Not Allowed) Apply for PA 18 531

Funding Number: PA 18 531
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $50,000
Early-life Factors and Cancer Development Later in Life (R21 - Clinical Trial Not Allowed) Apply for PA 18 532

Funding Number: PA 18 532
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Early-life Factors and Cancer Development Later in Life (R01 - Clinical Trial Not Allowed) Apply for PA 18 529

Funding Number: PA 18 529
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Research on the Mechanisms and/or Behavioral Outcomes of Multisensory Processing (R01 - Clinical Trial Optional) Apply for PA 18 545

Funding Number: PA 18 545
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
International Research Scientist Development Award (IRSDA) (K01) - Independent Clinical Trial Not Allowed Apply for PAR 18 539

Funding Number: PAR 18 539
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
International Research Scientist Development Award (IRSDA) (K01) - Independent Clinical Trial Required Apply for PAR 18 540

Funding Number: PAR 18 540
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Limited Competition: Clinical Research Sites for MACS/WIHS Combined Cohort Study, MACS/WIHS-CCS (U01-Clinical Trials Not Allowed) Apply for RFA HL 19 008

Funding Number: RFA HL 19 008
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Partnership for Aging and Cancer Research (U01 - Clinical Trial Not Allowed) Apply for PAR 18 552

Funding Number: PAR 18 552
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $75,000
Limited Competition: Data Analysis and Coordination Center for the MACS/WIHS Combined Cohort Study, MACS/WIHS-CCS (U01 Clinical Trials Not Allowed) Apply for RFA HL 19 007

Funding Number: RFA HL 19 007
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) Apply for PAR 18 559

Funding Number: PAR 18 559
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trials Required) Apply for PAR 18 560

Funding Number: PAR 18 560
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Cutting-Edge Basic Research Awards (CEBRA) (R21-Clinical Trial Optional) Apply for PAR 18 437

Funding Number: PAR 18 437
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 510", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: